| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |